Y-Intercept (HK)’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-12,668
Closed -$45.4K 1186
2022
Q4
$45.4K Buy
+12,668
New +$54.1K 0.01% 919
2022
Q2
Sell
-21,614
Closed -$184K 873
2022
Q1
$184K Buy
+21,614
New +$152K 0.04% 632

Other funds holding SRTA

Y-Intercept (HK)'s SRTA Position: Q1 2023 in Review

Y-Intercept (HK) sold out of Strata Critical Medical Inc (SRTA) in Q1 2023, closing a stake of 12,668 shares — an estimated $45.4K sold.

Y-Intercept (HK) first reported a position in SRTA in Q1 2022 and held it in 2 quarters. The position peaked at $184K in Q1 2022. 93 funds tracked by Wall St. Rank hold SRTA as of Q1 2023.

  • Y-Intercept (HK) reported no remaining Strata Critical Medical Inc position as of Q1 2023 after selling out during the quarter.
  • Y-Intercept (HK) sold 12,668 Strata Critical Medical Inc shares in Q1 2023, an estimated $45.4K.
  • Y-Intercept (HK) first reported a position in Strata Critical Medical Inc in Q1 2022 and held it in 2 quarters.
  • Y-Intercept (HK)'s Strata Critical Medical Inc position peaked at $184K in Q1 2022.
  • 93 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2023.

Based on Y-Intercept (HK)'s 13F filing for Q1 2023, filed 9 May 2023.